Fireship: Software and AI News
Midjourney has a new side quest... death
Regular videos from April–October 2026
A dated collection of Fireship's regular videos published from 20 April through 20 October 2026, with individual English summaries. Covers software, AI, and technology news. The summaries distinguish technical explanations from reported claims, subjective demonstrations, predictions, satire, and sponsorships. This is an editorial selection from the channel's uploads, not an official course or a summary of its full archive.
In this collection Browse 52 summaries 37 of 52
Fireship describes a proposed Midjourney medical-imaging program and spa, balancing its access ambitions against technical and regulatory limits. This summary uses English auto-generated captions, not medical research, regulatory records, or device inspection. Performance targets and health claims are attributed proposals, not established clinical capabilities or medical advice.
Key ideas
- The proposed ultrasonic CT device uses a water platform and a ring of small transmitters and receivers to gather acoustic measurements through the body. Fireship presents computational reconstruction of noisy signals as the connection to Midjourney's imaging expertise, not as proof that image-generation skill establishes diagnostic accuracy. 01:03–03:03(opens in a new tab)
- Midjourney's reported goal is a fast, accessible scan in a spa-like setting rather than a conventional referral-based imaging visit. The planned San Francisco site and future one-minute scan are ambitions; the video says the current prototype takes about 20 minutes. 02:05–04:08(opens in a new tab)
- Fireship reports doctors' objections that air and bone restrict useful ultrasound access, leaving important limitations for lungs and the brain. Software reconstruction is not presented as removing those physical constraints. The explanation is simplified and not a complete account of clinical ultrasound uses. 03:03–04:08(opens in a new tab)
- At the report date, Fireship says the device lacks FDA clearance and is limited to body-composition information. Research trials, disease-detection approval, later hardware, and a large deployment fleet are future milestones, not delivered medical services. 03:03–05:11(opens in a new tab)
Practical implications
Editorial: Separate a device's proposed convenience from evidence of clinical usefulness. Evaluate what anatomy it can assess, validated diagnostic performance, regulatory status, and the consequences of screening before treating frequent scans as a health benefit.
Questions and limits
Editorial: The report does not establish that broad screening improves outcomes or that the proposed scale is achievable. Drug references are jokes, not safety advice. Retool's closing production-app controls, survey percentage, and time-limited import offer are sponsored promotion. 00:00–01:03(opens in a new tab), 02:05–03:03(opens in a new tab), 04:08–05:26(opens in a new tab)
Full video: https://www.youtube.com/watch?v=a2i9h2ip-nY(opens in a new tab)